Dougherty analyst Eugene Mannheimer reiterated a Buy rating on Medidata Solutions (NASDAQ: MDSO) today and set a price target of $89. The company’s shares opened today at $79.
Mannheimer has an average return of 60.1% when recommending Medidata Solutions.
According to TipRanks.com, Mannheimer is ranked #950 out of 4793 analysts.
Medidata Solutions has an analyst consensus of Moderate Buy, with a price target consensus of $83.50.
See today’s analyst top recommended stocks >>
The company has a one-year high of $85.92 and a one-year low of $59.60. Currently, Medidata Solutions has an average volume of 616.7K.
Based on the recent corporate insider activity of 53 insiders, corporate insider sentiment is negative on the stock. Most recently, in March 2018, Glen De Vries, the President of MDSO sold 26,836 shares for a total of $1,877,983.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Medidata Solutions, Inc. provides cloud based solutions for life sciences that enhance the efficiency of customer’s clinical development processes from concept to conclusion, optimizing their research and development investments.
